nedaplatin has been researched along with Peritoneal Carcinomatosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chikazawa, K; Imai, K; Ishiguro, A; Kimura, A; Konno, R; Kuwata, T; Netsu, S; Wang, L | 1 |
| Fujiwara, K; Goto, T; Hasegawa, K; Iwasa, N; Nagao, S; Ohishi, R; Shimizu, M; Takano, M | 1 |
| Ota, T; Takeshima, N; Takizawa, K | 1 |
3 other study(ies) available for nedaplatin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Case-Control Studies; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies | 2020 |
Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Treatment Outcome | 2010 |
Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids | 2011 |